ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Charles Blanke Named Chair-Elect of SWOG

April 20, 2012

Heart Function Of Breast Cancer Patients Should Be Monitored, Two Studies Find

August 25, 2006

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

60 Minutes Report “Deception at Duke” Wins Peabody Award

March 29, 2013

In Brief: Holleb To Retire In June As ACS Vice President; Consensus Conference On Neurofibromatosis Set

January 23, 1987